
    
      This study aims to explore the best effective dose and adverse reaction of febuxostat in
      lowering serum uric acid to low level in patients with Chronic Renal Disease at different
      stages. To elucidate that low levels of serum uric acid can delay the progression of renal
      damage. Promote the application of anti uric acid drugs in the treatment of chronic renal
      failure and delay the progress of CKD in patients
    
  